Piramal Pharma Solutions

Piramal Pharma Solutions PPS is a CDMO offering end-to-end development and manufacturing solutions across the drug lifecycle.

We serve our clients through a globally integrated network of facilities in North America, Europe, and Asia. This enables us to offer a comprehensive range of services including Drug Discovery Solutions, Process & Pharmaceutical Development services, Clinical Trial Supplies, Commercial supply of APIs, and Finished dosage forms. We also offer specialized services like the development and manufactur

e of Highly Potent APIs and Antibody Drug Conjugation. Our capability as an integrated service provider & experience with various technologies enables us to serve Innovator and Generic companies worldwide. For more information and updates, please visit: www.piramalpharmasolutions.com

Biocatalysis is playing an increasingly important role in enabling more selective, efficient, and sustainable pathways i...
05/26/2026

Biocatalysis is playing an increasingly important role in enabling more selective, efficient, and sustainable pathways in drug discovery.

At Piramal Discovery Solutions in Ahmedabad, we leverage biocatalytic approaches to design greener and highly selective transformations supporting both early discovery and scale-up.

Our lab-scale development utilizes controlled systems such as glass reactors and incubator-based setups for whole-cell reactions, while scale-up is enabled through jacketed reactors with in-line monitoring of pH and temperature across aqueous, biphasic, and co-solvent systems.

Some of the ways we apply biocatalysis include:
- Chiral alcohol synthesis using alcohol dehydrogenases (ADHs) for enantiopure intermediates
- Kinetic resolution via lipase-catalyzed transesterification of racemates
- Green epoxidation using peroxygenases, avoiding heavy metals while maintaining high selectivity
- API amination through transaminases to access chiral amines

By integrating biocatalysis into our broader chemistry toolkit, we enable more sustainable and precise routes to complex molecules helping our partners accelerate innovation with efficiency and responsibility.

Not all molecules are straightforward, and that’s where expertise matters.Meet Brad Gold, Global Head of Formulations R&...
05/25/2026

Not all molecules are straightforward, and that’s where expertise matters.

Meet Brad Gold, Global Head of Formulations R&D, at CPhI Americas 2026.

From solubility and bioavailability challenges to scale-up considerations, Brad works with partners to design formulation strategies that enable success across development stages.

Bring your toughest formulation questions, we’re ready to solve them together.

Pennsylvania Convention Center
Booth 736

Antibody-drug conjugates (ADCs) are at the forefront of oncology innovation, combining targeted delivery with potent the...
05/22/2026

Antibody-drug conjugates (ADCs) are at the forefront of oncology innovation, combining targeted delivery with potent therapeutic action to improve treatment outcomes.

With advancements across payload design, linker chemistry, and conjugation technologies, ADC pharma is evolving rapidly unlocking new possibilities across cancer care.

As complexity grows, integrated development models are becoming essential. At Piramal Pharma Solutions, we bring together expertise across the ADC lifecycle to help simplify development and accelerate progress from concept to commercialization.

Click on the link below to read the full story on our blog:
https://lnkd.in/dgZpgdrS

Not just one molecule, your entire pipeline.Meet Daniel Weissmueller, Director, Business Development, at CPhI Americas 2...
05/20/2026

Not just one molecule, your entire pipeline.

Meet Daniel Weissmueller, Director, Business Development, at CPhI Americas 2026.

Daniel works with partners to align development and manufacturing strategies across their portfolios ensuring consistency, efficiency, and scalability from early-stage assets to commercial programs.

Let’s talk about how we can support your pipeline, end-to-end.

Pennsylvania Convention Center
Booth 736
Schedule a meeting with our team in advance: [email protected].

Earlier this month, leading Indian companies attended the 2026 SelectUSA Investment Summit, where they pledged over $20....
05/19/2026

Earlier this month, leading Indian companies attended the 2026 SelectUSA Investment Summit, where they pledged over $20.5 billion to the US pharmaceuticals, advanced manufacturing, energy infrastructure, and emerging technologies industries.

With over $19.1 billion of that total comprising investments from Indian pharma into US manufacturing, research, and development, and facility expansions, these contributions are expected to generate thousands of jobs and boost innovation in both regions.

At Piramal Pharma Solutions, we’re proud to be at the forefront of these plans, building on our longstanding commitment to US-based development and manufacturing. Over the last year, we’ve been rolling out a $90 million investment plan across our US facilities to deliver greater speed, scalability, and supply chain security to our partners — and we’re just getting started.

Discover how our US-based facilities have grown, and learn how they can accelerate your success at the links below.

-https://ppsazdevwebsitestg.blob.core.windows.net/public/uploads/generic_file_upload/210825073135-Piramal-Pharma-Solutions-and-NewAmsterdam-Pharma-Invest-in-Dedicated-Suite-to-Enhance-Oral-Solid-Dosage-Production-Capabilities.pdf

-https://ppsazdevwebsitestg.blob.core.windows.net/public/uploads/generic_file_upload/300625065655-Lexington-Expansion-Groundbreaking-Press-Release-Final.pdf

-https://ppsazdevwebsitestg.blob.core.windows.net/public/uploads/generic_file_upload/120525115627-Piramal-Pharma-Ltd-Continues-to-Invest-In-USA.pdf

- https://www.piramalpharmasolutions.com/contact-us

Targeted protein degradation is redefining what’s possible in drug discovery and PROTACs are at the forefront of this sh...
05/18/2026

Targeted protein degradation is redefining what’s possible in drug discovery and PROTACs are at the forefront of this shift.​

At Piramal Discovery Solutions in Ahmedabad, we offer specialized expertise in PROTAC synthesis supporting programs from early discovery through to multi-gram scale.​

​With their unique ability to selectively degrade target proteins, PROTACs open new avenues beyond the limitations of traditional small molecule inhibitors enabling access to previously challenging targets.​

Our capabilities include:​
- Versatile PROTAC scaffold synthesis, including CRBN, IAP, VHL, and DCAF1 E3 ligands​
- Design and synthesis of novel linkers, scalable up to multi-gram quantities​
- Efficient purification using advanced techniques such as SFC, RP-flash, and RP-HPLC​
- Rapid library synthesis to accelerate screening and optimization (typically 25–100 mg scale)​

​By combining deep synthetic expertise with scalable ex*****on, we help accelerate targeted protein degradation programs bringing the next
generation of therapeutics closer to reality.​

The journey from molecule to medicine begins with the development of a robust API. As the industry shifts toward more sp...
05/18/2026

The journey from molecule to medicine begins with the development of a robust API. As the industry shifts toward more specialised and complex therapies, API manufacturing has become central to delivering safe and effective treatments.​

Through a combination of technical expertise, scalable infrastructure and integrated processes, it ensures consistency, compliance and efficiency across the lifecycle. It also plays a key role in enabling faster timelines and reducing development risks.​

Head to our blog to explore the full API manufacturing journey:
https://www.piramalpharmasolutions.com/resources/blogs/api-manufacturing-guide-for-pharma-companies​

Sustainability at Piramal Pharma Solutions begins long before a formulation takes shape. It influences the choices we ma...
05/15/2026

Sustainability at Piramal Pharma Solutions begins long before a formulation takes shape. It influences the choices we make, the processes we follow and the outcomes we aim to deliver.​

Every stage, from sourcing to manufacturing, is guided by the need to reduce environmental impact without compromising on performance all because responsible progress is built into every decision.​

Visit our website to learn more about sustainable practices.
https://lnkd.in/dASYk-NC

As the demand for ADCs and bioconjugates continues to grow, expanding specialized development and manufacturing capabili...
05/14/2026

As the demand for ADCs and bioconjugates continues to grow, expanding specialized development and manufacturing capabilities remains critical.

That’s why Piramal Pharma Solutions is proud to introduce a new state-of-the-art payload-linker suite at our Riverview, Michigan facility.

This expansion enhances our ability to provide integrated support for payload-linker development and manufacturing, complementing the site’s existing API and HPAPI expertise to better serve global biopharma partners developing complex therapies.

By continuing to invest in advanced infrastructure and scientific expertise, we aim to help accelerate innovation and support the successful delivery of next-generation therapeutics worldwide.

Read the press release here:https://ppsazdevwebsitestg.blob.core.windows.net/public/uploads/generic_file_upload/130526132020-Piramal-Pharma-Solutions-Unveils-State-of-the-Art-Payload-Linker---Suite-at-its-Riverview,-Michigan-Facility.pdf

Meet our team at Booth 736.As we gear up for CPhI Americas 2026 this June at the Pennsylvania Convention Center, we’re e...
05/13/2026

Meet our team at Booth 736.
As we gear up for CPhI Americas 2026 this June at the Pennsylvania Convention Center, we’re excited to have Lindsay Bruttomesso from our North America Business Development team on-site.

Lindsay Bruttomesso, MBA works closely with partners to navigate complex development and manufacturing needs, bringing the right expertise, capabilities, and global network together to move projects forward with confidence.

Whether you're advancing a molecule or scaling toward commercialization, connect with Lindsay to explore how we can support your next milestone.

Booth 736

Schedule a meeting with our team in advance: [email protected]

hashtag

Address

18655 Krause Street
Riverview, MI
48193

Alerts

Be the first to know and let us send you an email when Piramal Pharma Solutions posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share